TACR3 and Kallmann syndrome: Disruption of these pathways have been previously linked to CHH (olfactory dysfunction (anosmia) and hypogonadotropic hypogonadism in Kallmann Syndrome; TAC3R variants in CHH61) but not to ovary insufficiency phenotypes.